Table 5.
MVA of the progression-free rate
Parameter | p value | HR (95% CI) |
---|---|---|
Age (≥ 50 vs. < 50 years) | 0.159 | 2.369 (0.712–7.878) |
Gender (male vs. female) | 0.114 | 0.320 (0.078–1.312) |
ECOG (3–4 vs 0–2) | 0.258 | 2.292 (0.544–9.650) |
Size (≥ 5 cm vs. < 5 cm) | 0.819 | 1.213 (0.232–6.350) |
OP method (non-gross total vs. gross total) | 0.023 | 7.408 (1.320–41.585) |
RT field (whole brain vs. small) | 0.609 | 0.716 (0.202–2.535) |
Galectin-1 (strong vs. weak) | 0.037 | 6.080 (1.113–33.219) |
Galectin-3 (strong vs. weak) | 0.089 | 0.181 (0.025–1.299) |
MVA multivariate statistical analysis, ECOG Eastern Cooperative Oncology Group, OP operation, RT radiotherapy